MONROVIA, Calif.--(BUSINESS WIRE)-- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases ...
Antibody specialist Xencor has a new chief medical officer: Allen Yang, M.D., Ph.D., who joins the company from Jazz Pharmaceuticals. As a senior vice president at Jazz, Yang headed clinical ...
Soulaiman Itani and Allen Yang of Atheer talk with Katie Boehret about how their personality quirks and sleep deficiencies have helped and hindered product work.